Digest Network How does it work
Network
/
Society
ās
Not verified

āshibio

What we write about

BiotechnologyHealthIndustriaMedicine - variousPharmaceuticals

5 Press releases

View all press releases
08/09/2025
Biotechnology
Pharmaceuticals
Health
Medicine - various
Eventi
āshibio Reports Promising Preclinical Data for Two First-in-Class Antibodies Targeting Debilitating Bone Disorders at ASBMR Meeting
Source
āshibio
Issuer
Business Wire
1.00
0
19/08/2025
Health
Food hygiene
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Finance
Industria
āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2
Source
āshibio
Issuer
Business Wire
1.00
0
24/06/2025
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Industria
āshibio Doses First Patient in Phase 1b Trial of Andecaliximab in Patients with Spinal Cord Injury (SCI) at Risk of Heterotopic Ossification (HO)
Source
āshibio
Issuer
Business Wire
1.00
0
23/01/2025
Industria
Health
Food hygiene
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
āshibio Doses First Patient in ANDECAL study, a Phase 2/3 Trial of Andecaliximab for Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
Source
āshibio
Issuer
Business Wire
1.00
0
17/09/2024
Labour market
Biotechnology
Health
Pharmaceuticals
Medicine - various
āshibio Announces Appointment of Dipal Doshi, CEO of Entrada Therapeutics, to its Board of Directors
Source
āshibio
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0